US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 121 actively recruiting studies with Louisiana sites out of 121 registered in total. The busiest research areas in Louisiana are Obesity, Crohn's Disease, Asthma. Leading sponsors running trials in the state include National Cancer Institute (NCI), Pennington Biomedical Research Center, Eli Lilly and Company. By stage, Louisiana trials break down as Phase 1 (5), Phase 2 (29), Phase 3 (48), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
121
Recruiting Now
121
← Back to US Map
Top Conditions in Louisiana
Obesity (4)Crohn's Disease (4)Asthma (3)Overweight (3)Heart Failure (2)Sickle Cell Disease (2)Systemic Lupus Erythematosus (2)Clear Cell Renal Cell Carcinoma (2)Chronic Lymphocytic Leukemia (2)Alzheimer Disease (2)Breast Cancer (2)Adult Spinal Deformity (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 121 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 121. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Obesity, Crohn's Disease, Asthma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT04797286 Phase 2
Recruiting
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Condition
Scleroderma
Enrollment
30 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT06979453 Phase 3
Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BM...
Condition
Plaque Psoriasis
Enrollment
366 pts
Location
United States, Argentina, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07076407 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X...
Condition
Major Depressive Disorder
Enrollment
450 pts
Location
United States, Finland, Poland
Sponsor
Xenon Pharmaceuticals Inc.
View Trial →
NCT06667700 Phase 3
Recruiting
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Dise...
Condition
Coronavirus Disease (COVID-19)
Enrollment
3,082 pts
Location
United States, Argentina, Brazil
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07546929 Phase 2
Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Di...
Condition
Type 2 Diabetes
Enrollment
300 pts
Location
United States
Sponsor
Housey Healthcare ULC
View Trial →
NCT07184931 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Crohn's Disease
Enrollment
980 pts
Location
United States, Argentina, Australia
Sponsor
Sanofi
View Trial →
NCT05080673 N/A
Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Condition
Adenocarcinoma of the Colon
Enrollment
9,500 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
View Trial →
NCT05227053 N/A
Recruiting
STOP AF First Post-Approval Study
Condition
Paroxysmal Atrial Fibrillation
Enrollment
200 pts
Location
United States
Sponsor
Medtronic Cardiac Ablation Sol
View Trial →
NCT06933472 Phase 3
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosp...
Condition
Hyperphosphatemia
Enrollment
264 pts
Location
United States, China
Sponsor
Alebund Pharmaceuticals
View Trial →
NCT07542873 N/A
Recruiting
Iron Absorption in The Low Oxygen Exposure and Weight Status (LOWS) Study
Condition
Obesity (Disorder)
Enrollment
30 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
View Trial →
NCT06868212 Phase 3
Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Time...
Condition
Chronic Spontaneous Urticaria (CSU)
Enrollment
400 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07216703 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembro...
Condition
Cervical Cancer
Enrollment
1,023 pts
Location
United States, Argentina, Austria
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06753045 N/A
Recruiting
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and T...
Condition
Heart Diseases
Enrollment
10,000 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT06073431 N/A
Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Condition
Advanced Colorectal Carcinoma
Enrollment
800 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT06647953 Phase 3
Recruiting
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropul...
Condition
Pleuropulmonary Blastoma
Enrollment
110 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06070194 N/A
Recruiting
Cardiovascular Risk and Circadian Misalignment in Short Sleepers - Role of Exten...
Condition
Sleep Deprivation
Enrollment
100 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT06072612 Phase 3
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastat...
Condition
Breast Cancer
Enrollment
404 pts
Location
United States
Sponsor
BriaCell Therapeutics Corporat
View Trial →
NCT05986292 Phase 2
Recruiting
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices ...
Condition
Osteoarthritis, Knee
Enrollment
10,000 pts
Location
United States, Puerto Rico
Sponsor
Eli Lilly and Company
View Trial →
NCT05677971 Phase 3
Recruiting
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People ...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
160 pts
Location
United States, Australia, Austria
Sponsor
Takeda
View Trial →
Page 5 of 5 — 121 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology